A retrospective cohort study on oesophageal food bolus obstruction in the North Denmark region in 2021-two thirds were never diagnosed with a cause.
Eosinophilic oesophagitis
Food Bolus Impaction
Food Bolus obstruction
Oesophageal cancer
Oesophagus
Upper Endoscopy
Journal
BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547
Informations de publication
Date de publication:
02 Jan 2024
02 Jan 2024
Historique:
received:
19
06
2023
accepted:
06
12
2023
medline:
4
1
2024
pubmed:
4
1
2024
entrez:
3
1
2024
Statut:
epublish
Résumé
Food bolus obstruction (FBO) leading to hospital treatment is often associated with eosinophilic oesophagitis (EoE), stenosis, or oesophageal cancer (1). Danish national guidelines recommend that patients with FBO undergo a diagnostic upper endoscopy within two weeks of presentation to exclude possible malignancy, and histological evaluation of eight biopsies (2, 3). The aims of this study were to (1) report the incidence and describe the causes and treatment of FBO in the North Denmark Region (NDR), (2) determine the proportion of patients who underwent upper endoscopy and biopsy according to regional and national guidelines, and (3) identify International Classification of Diseases 10th Revision (ICD-10) diagnosis and procedure codes applied to the hospital visits due to FBO in the NDR. Among all acute hospital visits in the NDR in 2021, all visits with ICD-10 codes possibly reflecting FBO, as well as a random sample of 14,400 visits with unspecific ICD-10 codes (R and Z codes), were screened manually for possible FBO. Diagnosis, follow-up, and treatment of all patients with FBO were recorded. The median patient age was 66.0 (Q1-Q3: 49.8-81.0) years, and half of the patients had experienced FBO before. Two thirds of patients (66.0%) were never diagnosed with a cause of FBO, followed by 17.3% with EoE. 30% of patients did not undergo upper endoscopy within two weeks of the hospital visit, and 50.7% were never biopsied in the oesophagus. Of 1886 hospital visits with registry ICD-10 codes that possibly reflected FBO, 8.4% were due to FBO, while FBO was present in 0.028% of the random sample of unspecific ICD-10 codes. Most hospitalized FBO patients in the NDR in 2021 were never diagnosed with a cause. In these patients there is a high risk of overlooked EoE or upper gastrointestinal cancers. The area needs immediate focus and changed routines to improve treatment and prevent new FBO.
Sections du résumé
BACKGROUND
BACKGROUND
Food bolus obstruction (FBO) leading to hospital treatment is often associated with eosinophilic oesophagitis (EoE), stenosis, or oesophageal cancer (1). Danish national guidelines recommend that patients with FBO undergo a diagnostic upper endoscopy within two weeks of presentation to exclude possible malignancy, and histological evaluation of eight biopsies (2, 3).
AIMS
OBJECTIVE
The aims of this study were to (1) report the incidence and describe the causes and treatment of FBO in the North Denmark Region (NDR), (2) determine the proportion of patients who underwent upper endoscopy and biopsy according to regional and national guidelines, and (3) identify International Classification of Diseases 10th Revision (ICD-10) diagnosis and procedure codes applied to the hospital visits due to FBO in the NDR.
METHODS
METHODS
Among all acute hospital visits in the NDR in 2021, all visits with ICD-10 codes possibly reflecting FBO, as well as a random sample of 14,400 visits with unspecific ICD-10 codes (R and Z codes), were screened manually for possible FBO. Diagnosis, follow-up, and treatment of all patients with FBO were recorded.
RESULTS
RESULTS
The median patient age was 66.0 (Q1-Q3: 49.8-81.0) years, and half of the patients had experienced FBO before. Two thirds of patients (66.0%) were never diagnosed with a cause of FBO, followed by 17.3% with EoE. 30% of patients did not undergo upper endoscopy within two weeks of the hospital visit, and 50.7% were never biopsied in the oesophagus. Of 1886 hospital visits with registry ICD-10 codes that possibly reflected FBO, 8.4% were due to FBO, while FBO was present in 0.028% of the random sample of unspecific ICD-10 codes.
CONCLUSIONS
CONCLUSIONS
Most hospitalized FBO patients in the NDR in 2021 were never diagnosed with a cause. In these patients there is a high risk of overlooked EoE or upper gastrointestinal cancers. The area needs immediate focus and changed routines to improve treatment and prevent new FBO.
Identifiants
pubmed: 38166672
doi: 10.1186/s12876-023-03077-8
pii: 10.1186/s12876-023-03077-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3Informations de copyright
© 2023. The Author(s).
Références
Birk M, Bauerfeind P, Deprez P, Häfner M, Hartmann D, Hassan C et al. Removal of foreign bodies in the upper gastrointestinal tract in adults: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy [Internet]. 2016;48(05):489–96. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L608327673&from=export .
Andersen IB, Bremholm L, Havelund T, Jørgensen SP, Lund Krarup A, Mohammadi M et al. Dansk Selskab for Gastroenterologi og Hepatologi. 2020 [cited 2023 Mar 13]. Eosinofil øsofagitis. Available from: https://dsgh.dk/wp-content/uploads/2022/06/EoE.pdf .
Sundhedsstyrelsen. Pakkeforløb for kræft i spiserør, mavesæk og mavemund [Internet]. 2023 [cited 2023 Jun 13]. p. 1–30. Available from: https://www.sst.dk/-/media/Udgivelser/2023/Kraeft/Pakkeforloeb-spiseroer-mavesaek/Pakkeforloeb.ashx .
Sugawa C, Ono H, Taleb M, Lucas CE. Endoscopic management of foreign bodies in the upper gastrointestinal tract: a review. World J Gastrointest Endosc. 2014;6(10):475–81.
doi: 10.4253/wjge.v6.i10.475
pubmed: 25324918
pmcid: 4198392
Ko HH, Enns R. Review of food bolus management. Canadian Journal of Gastroenterology [Internet]. 2008;22(10):805–8. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L354174791&from=export .
Hardman J, Sharma N, Smith J, Nankivell P. Conservative management of oesophageal soft food bolus impaction. Cochrane Database of Systematic Reviews [Internet]. 2020;2020(5). Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L631728422&from=export .
Ntuli Y, Bough I, Wilson M. Recognising eosinophilic oesophagitis as a cause of food bolus obstruction. Frontline Gastroenterol [Internet]. 2020;11(1):11–5. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L630233902&from=export .
Lenz CJ, Leggett C, Katzka DA, Larson JJ, Enders FT, Alexander JA. Food impaction: Etiology over 35 years and association with eosinophilic esophagitis. Diseases of the Esophagus [Internet]. 2019;32(4). Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L630233902&from=exportid=L628085409&id=L630233902&from=exportfrom=export .
Hoversten P, Lomeli L, Broman AT, Gaumnitz E, Hillman L. Esophageal Disease and loss to follow-up are common among patients who experience non-endoscopic resolution of food impaction. Dis Esophagus. 2023;36(3).
Fulforth JM, Chen AJ, Falvey JD. Early referral for endoscopy is the most appropriate management strategy in cases of food bolus obstruction. Emergency Medicine Australasia [Internet]. 2019;31(5):745–9. Available from: https://onlinelibrary.wiley.com/doi/ https://doi.org/10.1111/1742-6723.13238 .
Schupack DA, Lenz CJ, Geno DM, Tholen CJ, Leggett CL, Katzka DA et al. The evolution of treatment and complications of esophageal food impaction. United European Gastroenterol J [Internet]. 2019;7(4):548–56. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L630233902&from=exportid=L626727659&id=L630233902&from=exportfrom=export .
Allin KH, Poulsen G, Melgaard D, Frandsen LT, Jess T, Krarup AL. Eosinophilic oesophagitis in Denmark: Population-based incidence and prevalence in a nationwide study from 2008 to 2018. United Eur Gastroenterol J. 2022;10(7):640–50.
doi: 10.1002/ueg2.12273
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
doi: 10.1016/j.jbi.2019.103208
pubmed: 31078660
pmcid: 7254481
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.
doi: 10.1016/j.jbi.2008.08.010
pubmed: 18929686
Chang JW, Olson S, Kim JY, Dolan R, Greenson J, Sanders G et al. Loss to follow-up after food impaction among patients with and without eosinophilic esophagitis. Dis Esophagus. 2019;32(12).
Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA et al. Eosinophilic esophagitis: Updated consensus recommendations for children and adults. Journal of Allergy and Clinical Immunology [Internet]. 2011;128(1):3–20. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L630233902&from=exportid=L51361918&id=L630233902&from=exportfrom=export .
Warners MJ, Oude Nijhuis RAB, De Wijkerslooth LRH, Smout AJPM, Bredenoord AJ. The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort. American Journal of Gastroenterology [Internet]. 2018;113(6):836–44. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L630233902&from=exportid=L621915463&id=L630233902&from=exportfrom=export .
Krarup AL, Drewes AM, Ejstrud P, Laurberg PT, Vyberg M. Implementation of a biopsy protocol to improve detection of esophageal eosinophilia: a Danish registry-based study. Endoscopy. 2021;53(1):15–24.
doi: 10.1055/a-1206-0852
pubmed: 32757199
Dhar A, Haboubi HN, Attwood SE, Auth MKH, Dunn JM, Sweis R, et al. British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults. Gut. 2022;71(8):1459–87.
pubmed: 35606089
Stadler J, Hölscher AH, Feussner H, Dittler J, Siewert JR. The steakhouse syndrome. Primary and definitive diagnosis and therapy. Surg Endosc. 1989;3(4):195–8.
doi: 10.1007/BF02171545
pubmed: 2623551
Heunicke M. Bekendtgørelse af lov om videnskabsetisk behandling af sundhedsvidenskabelige forskningsprojekter og sundhedsdatavidenskabelige forskningsprojekter [Internet]. 2020 [cited 2023 Aug 9]. p. 1–21. Available from: https://www.retsinformation.dk/eli/lta/2020/1338 .